INTECH INVESTMENT MANAGEMENT LLC
Position in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 1086318
WEST PALM BEACH, FL
Position in AMLX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$346,401
-$40,231 QoQ
Shares Held
24,921
-22.1% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026INTECH INVESTMENT MANAGEMENT LLC holds $94,314,635 across 29 Drug Manufacturers - Specialty & Generic names. AMLX ranks #19 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
311,871 | $36,866,270 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
478,939 | $14,425,641 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
20,744 | $12,300,776 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
86,315 | $11,371,137 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
44,826 | $3,400,052 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
88,945 | $2,711,043 | |
| 7 | ALKS |
Alkermes plc.
|
60,967 | $2,155,793 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
38,984 | $2,015,082 |
All Filings in AMLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $346,401 | 24,921 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $386,632 | 32,006 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $264,923 | 19,494 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $232,779 | 36,315 | Shares | Sole | 2025-08-08 | |
| No filing history on record for this holder in this stock. | ||||||